Efficacy and Safety of Subcutaneous Garadacimab for the Prophylaxis of Hereditary Angioedema Attacks in Adults and Adolescent Patients with HAE: Results from a Multicenter, Placebo-Controlled Phase 3 Trial.

Details

Language :

English

ISSN :

00916749

Volume :

151

Issue :

2

Database :

Supplemental Index

Journal :

Journal of Allergy & Clinical Immunology

Publication Type :

Academic Journal

Accession number :

161727520

Full Text :

https://doi.org/10.1016/j.jaci.2022.12.414